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BACKGROUND AND PURPOSE
Sperm from many species share the sperm-specific Ca2+ channel CatSper that controls the intracellular Ca2+ concentration
and, thereby, the swimming behaviour. A growing body of evidence suggests that the mechanisms controlling the activity of
CatSper and its role during fertilization differ among species. A lack of suitable pharmacological tools has hampered the
elucidation of the function of CatSper. Known inhibitors of CatSper exhibit considerable side effects and also inhibit Slo3, the
principal K+ channel of mammalian sperm. The compound RU1968 was reported to suppress Ca2+ signaling in human sperm
by an unknown mechanism. Here, we examined the action of RU1968 on CatSper in sperm from humans, mice, and sea
urchins.
EXPERIMENTAL APPROACH
We resynthesized RU1968 and studied its action on sperm from humans, mice, and the sea urchin Arbacia punctulata by Ca2+
fluorimetry, single-cell Ca2+ imaging, electrophysiology, opto-chemistry, and motility analysis.
KEY RESULTS
RU1968 inhibited CatSper in sperm from invertebrates and mammals. The compound lacked toxic side effects in human sperm,
did not affect mouse Slo3, and inhibited human Slo3 with about 15-fold lower potency than CatSper. Moreover, in human sperm,
RU1968 mimicked CatSper dysfunction and suppressed motility responses evoked by progesterone, an oviductal steroid known
to activate CatSper. Finally, RU1968 abolished CatSper-mediated chemotactic navigation in sea urchin sperm.
CONCLUSION AND IMPLICATIONS
We propose RU1968 as a novel tool to elucidate the function of CatSper channels in sperm across species.
Abbreviations
2-AG, 2-arachidonoylglycerol; ABHD2, α/β hydrolase domain-containing protein 2; ASW, artificial sea water; [Ca2+]i,
intracellular Ca2+ concentration; CASA, computer-assisted sperm analysis; HSA, human serum albumin; HTF, human tubal
fluid; MES, 2-(N-Morpholino)ethanesulfonic acid; pHi, intracellular pH; sEBSS, supplemented Earle’s balanced salt
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solution; TAPS, N-[Tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid; TYH, Toyoda, Yokoyama and Hosi’s;
VAP, velocity average path; Vm, membrane potential
Introduction
The intracellular Ca2+ concentration ([Ca2+]i) modulates the
beat of the sperm flagellum and, thereby, the swimming be-
haviour (Publicover et al., 2008; Alvarez et al., 2014). In many
but not all species, [Ca2+]i is controlled by the sperm-specific
Ca2+ channel CatSper (cation channel of sperm) (Quill
et al., 2001; Ren et al., 2001, Kirichok et al., 2006; Lishko
et al., 2010; Loux et al., 2013; Seifert et al., 2015). CatSper
appeared early in evolution, before the branching of eukary-
otes into unikonts and bikonts (Cai and Clapham, 2008; Cai
et al., 2014; Chung et al., 2017). So far, most of our knowledge
about CatSper originates from physiological studies of native
channels in mammalian and sea urchin sperm. In general,
CatSper is activated by depolarization of the membrane po-
tential (Vm) and by alkalization of the intracellular pH (pHi)
(Kirichok et al., 2006; Lishko et al., 2010; Lishko et al., 2011;
Strünker et al., 2011; Seifert et al., 2015). In sea urchin sperm,
the egg’s chemoattractant evokes rapid changes in Vm and
pHi, stimulating Ca
2+ influx via CatSper (Seifert et al., 2015,
Espinal-Enríquez et al., 2017), which controls chemotactic
steering. Targeted ablation of genes encoding CatSper chan-
nel subunits provided insight into the function of CatSper
in mouse sperm (Quill et al., 2001; Ren et al., 2001; Carlson
et al., 2003; Carlson et al., 2005; Liu et al., 2007; Qi et al.,
2007; Wang et al., 2009; Chung et al., 2011; Zeng et al.,
2013; Chung et al., 2017). For instance, sperm from
CatSper/ mice suffer from impaired motility (Ren et al.,
2001; Qi et al., 2007;Miki and Clapham, 2013), fail to traverse
the oviduct (Ho et al., 2009; Miki and Clapham, 2013; Chung
et al., 2014), and are unable to penetrate the egg coat (Ren
et al., 2001), resulting in male infertility (Qi et al., 2007, Quill
et al., 2001, Ren et al., 2001). CatSper is essential for fertiliza-
tion also in humans. Mutations in CATSPER genes (Avenarius
et al., 2009; Hildebrand et al., 2010) and CatSper dysfunction
(Williams et al., 2015) are associated with male infertility.
However, mouse and human CatSper channels have distinct
properties, indicating that the channel might serve different
functions (Kaupp and Strünker, 2016; Alvarez, 2017). For ex-
ample, in human but not in mouse sperm, CatSper serves as
a polymodal sensor that integrates a range of different chem-
ical cues (Brenker et al., 2012; Schiffer et al., 2014; Brenker
et al., 2018): human CatSper is activated by progesterone
and prostaglandins (PGs) (Lishko et al., 2011; Strünker et al.,
2011; Brenker et al., 2012), hormones present in the oviductal
fluid (Schuetz and Dubin, 1981). The ensuing Ca2+ influx
controls the swimming behaviour and promotes the
penetration of the egg coat (Schaefer et al., 1998; Harper
et al., 2003; Oren-Benaroya et al., 2008; Publicover et al.,
2008; Baldi et al., 2009; Kilic et al., 2009; Alasmari et al.,
2013a; Schiffer et al., 2014; Tamburrino et al., 2014;
Tamburrino et al., 2015). Moreover, progesterone facilitates
the migration of human sperm in viscous medium
encountered by the sperm during their voyage across the
female genital tract (Alasmari et al., 2013b). However, in
humans, neither the role of CatSper nor that of progesterone
and PGs during fertilization has been fully established. The
function of CatSper in species other than sea urchin, mouse,
and human is largely unknown. To address these questions,
we rely on pharmacological tools that allow manipulating
the function of CatSper.
Several drugs have been identified that suppress CatSper
activity, for example,NNC-0396 (Lishko et al., 2011, Strünker
et al., 2011),mibefradil (Strünker et al., 2011), MDL12330A
(Brenker et al., 2012) and HC-056456 (Carlson et al., 2009).
In patch-clamp experiments, NNC-0396, mibefradil, and
MDL12330A abolish CatSper currents (Lishko et al., 2011,
Strünker et al., 2011, Brenker et al., 2012); HC-056456 attenu-
ates CatSper currents (Carlson et al., 2009), but it is unknown
whether the drug inhibits the channel completely. Of note,
none of these drugs is selective for CatSper. The drugs also
inhibit the sperm-specific K+ channel Slo3 (KCa5.1)
(Navarro et al., 2007; Carlson et al., 2009; Brenker et al.,
2014; Mansell et al., 2014), the principal K+ channel in mouse
(Santi et al., 2010; Zeng et al., 2011) and human sperm
(Brenker et al., 2014). Notably, each drug inhibits CatSper
and Slo3 with similar potency. Moreover, NNC-0396,
mibefradil, and MDL12330A exhibit serious adverse actions
in human sperm. At the high micromolar concentrations
required to abolish Ca2+ influx via CatSper channels, NNC-
0396 and mibefradil evoke a sizeable and sustained increase
of [Ca2+]i and pHi (Strünker et al., 2011; Brenker et al., 2012;
Chávez et al., 2017) and stimulate acrosomal exocytosis
(Chávez et al., 2017; Supporting Information Figure S3).
Similarly, MDL12330A at high micromolar concentrations
also evokes a sustained [Ca2+]i increase in human sperm
(Brenker et al., 2012). Finally, the drugs affect the vitality
and overall motility of sperm (Tamburrino et al., 2014)
(Supporting Information Figure S3). HC-056456 has not been
further characterized in human sperm, because it is not com-
mercially available. In conclusion, novel potent and selective
CatSper inhibitors without toxic side effects are required.
Before the identification of CatSper channels, the
steroidal sigma receptor ligand RU1968 was reported to
suppress progesterone- and PG-induced Ca2+ signals in
human sperm (Schaefer et al., 2000). The mechanism of
RU1968 action in sperm has remained unclear, except that
it did not involve the activation of sigma receptors (Schaefer
et al., 2000). We wondered whether RU1968 might inhibit
CatSper and re-examined the actions of this compound in
sperm.
Here, we show that RU1968 potently abolishs Ca2+
signals mediated by CatSper in mouse, human, and sea
urchin sperm. Patch-clamp recordings from mouse and
human sperm confirmed that RU1968 inhibits CatSper. This
compound does not affect mouse Slo3 and inhibits human
Slo3 channels with about 15-fold lower potency than human
CatSper. When present during the capacitation process,
RU1968 suppressed hyperactivation in human sperm and
inhibited progesterone-evoked motility responses, showing
that these effects involve Ca2+ influx via CatSper. Finally, we
demonstrate that RU1968 abolishs chemotaxis of sea urchin
sperm. In summary, RU1968 is a potent cross-species
inhibitor of CatSper channels that is selective for CatSper
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over Slo3. This compound seems well-suited to study CatSper
channel function in sperm from invertebrates to mammals.
Methods
Sperm preparation
The studies involving human sperm were performed in agree-
ment with the standards set by the Declaration of Helsinki.
Samples of human semen were obtained from volunteers
with their prior written consent. We obtained approval from
the institutional ethics committees of the medical associa-
tion Westfalen-Lippe and the Medical Faculty of the Univer-
sity of Münster (4INie) and from the ethical committee of
the University of Birmingham Life and Health Sciences
(ERN12-0570R).
For Ca2+ fluorimetry in sperm populations, single-cell
Ca2+ imaging, patch-clamp recordings, single-cell motility
studies and assays for acrosomal exocytosis and viability,
sperm were purified by the swim-up procedure in human
tubal fluid (HTF) medium containing (in mM): 93.8 NaCl,
4.69 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33
Na-pyruvate, 21.4 lactic acid, 2.78 glucose, 21 HEPES and 4
NaHCO3, pH 7.35 (adjusted with NaOH). Sperm were washed
and re-suspended in HTF containing 3 mg·mL1 human se-
rum albumin (HSA, Irvine Scientific, Santa Ana, CA, USA).
For Kremer test, sperm were purified by the swim-up proce-
dure in Supplemented Earle’s balanced salt solution (sEBSS),
containing (in mM): 98.5 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2,
5.5 glucose, 25 NaHCO3, 2.5 Na-pyruvate, 19 Na-lactate, 0.81
MgSO4, 15 HEPES and 0.3% BSA, pH 7.4 (adjusted with
NaOH). Before experiments, spermwere incubated for at least
300 min at 37°C in a 5% CO2 atmosphere.
For computer-assisted sperm analysis (CASA), sperm were
purified by the swim-up procedure in HTF lacking NaHCO3
and HSA. Sperm were washed and re-suspended in this me-
dium (non-capacitating conditions) or in HTF fortified with
25 mM NaHCO3 and 3 mg·mL1 HSA (capacitating condi-
tions). Before experiments, sperm were incubated for at least
300 min at 37°C and 5% CO2 atmosphere.
All animal care and experimental procedures complied
with the Guidelines set by the Animal Center of Nanchang
University (Approval: SYXK2010-0002) and of the German An-
imal Welfare Act and the district veterinary office under ap-
proval by the LANUV (AZ.02.05.50.16.011 and AZ.84-
02.04.2012.A192). Animal studies are reported in compliance
with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath
and Lilley, 2015). C57BL/6N wild-type (from Janvier, Le
Genest-Saint-Isle, France) and C57BL/6N CatSper1/ mice [a
kind gift from Prof. David Clapham (Howard Hughes Medical
Institute, Janelia Research Campus, USA; Ren et al. 2011)] were
kept under specific pathogen-free conditions and in ventilated
cages (Greenline, Tecniplast). Maximally five mice were housed
per cage.
Mouse epididymides were obtained from at least 15-week-
old male mice that were anaesthetized with CO2 or isoflurane
(Abbvie Deutschland, Ludwigshafen, Germany) and killed by
cervical dislocation. For patch-clamp recordings, sperm were
isolated from the cauda epididymis by swim-out in HS solu-
tion containing (in mM): 135 NaCl, 5 KCl, 1 MgSO4, 2 CaCl2,
20 HEPES, 5 glucose, 10 lactic acid, 1 Na-pyruvate, pH 7.4
(adjusted with NaOH). After 20 min swim-out at 37°C and
10% CO2, the supernatant was collected. Sperm were washed
twice and re-suspended in HS solution. For Ca2+ fluorimetry,
sperm were isolated by swim-out in Toyoda, Yokoyama and
Hosi (TYH) medium containing (in mM): 138 NaCl, 4.8 KCl,
2 CaCl2, 1.2 KH2PO4, 1 MgSO4, 5.6 glucose, 0.5 Na-pyruvate,
10 Na-lactate, 10 HEPES, pH 7.4 (adjusted with NaOH). After
15 min swim-out at 37°C and 5% CO2, sperm were counted
and capacitated in TYH-medium supplemented with 25 mM
NaHCO3 and 3 mg·mL
1 BSA.
Sperm from the sea urchin Arbacia punctulata were ob-
tained by injecting 0.5 M KCl into the body cavity or electri-
cal stimulation of the animal. The ejaculate (‘dry sperm’)
was diluted in artificial sea water (ASW) containing (in mM):
423 NaCl, 9.27 CaCl2, 9 KCl, 22.94 MgCl2, 25.5 MgSO4, 0.1
EDTA, 10 HEPES, pH 7.8 (adjusted with NaOH).
Measurement of changes in intracellular Ca2+
In human sperm populations, changes in [Ca2+]i and pHi
were measured with the fluorescent Ca2+ indicator Fluo4
and BCECF (Thermo Fisher, Waltham, MA, USA), respec-
tively, in 384 multi-well plates in a fluorescence plate reader
(Fluostar Omega, BMG Labtech, Ortenberg, Germany) at
29°C, or in a rapid-mixing device in the stopped-flow mode
(SFM400, Bio-Logic, Grenoble, France) at 37°C. Sperm were
loaded with Fluo4-AM (10 μM) in the presence of Pluronic
F-127 (0.05% w/v) at 37°C for 45min or with BCECF-AM
(10 μM) at 37°C for 15min. After incubation, excess dye was
removed by centrifugation at 700× g, for 10min, room tem-
perature. Sperm concentration was adjusted to 5 × 106
cells·mL1 in HTF and equilibrated for 5 min at 29°C
(Fluostar) or 37°C (stopped-flow).
In plate-reader experiments, wells were filled with 50 μL
of the sperm suspension; the fluorescence was excited at
480 nm (Fluo-4) or 440 and 480 nm (dual excitation, BCECF),
and fluorescence emission was recorded at 520 nm. Fluores-
cence was monitored before and after injection of 25 μL (1:3
dilution) RU1968F1, followed after 5 min by injection of
stimuli (1:10 dilution). The solutions were injected into the
wells with an electronic multichannel pipette. Changes in
Fluo-4 fluorescence are depicted as ΔF/F (%), that is, the
change in fluorescence (ΔF) relative to themean basal fluores-
cence (F) before application of buffer or stimuli, to correct for
intra- and inter-experimental variations in basal fluorescence
among individual wells. Changes in BCECF-fluorescence ra-
tio (R, 480/440 nm) are depicted as ΔR/R (%), that is, the
change in ratio (ΔR) relative to the mean basal ratio (R) before
application of buffer or stimuli, to correct for intra- and inter-
experimental variations in the basal fluorescence ratio among
individual wells. In stopped-flow experiments, the sperm sus-
pension was rapidly mixed (1:1; flow rate = 1 mL·s1) with
HTF containing RU1968F1 and other stimuli, or with K8.6-,
KCl-, or pHo8.6-HTF containing RU1968F1. Fluorescence
was excited with a SpectraX Light Engine modulated at
10 kHz (Lumencor, Beaverton, OR, USA) and passed through
a 494/20 nm excitation filter (Semrock, Buffalo, NY, USA).
Emission was passed through a 536/40 nm filter (Semrock)
and recorded with a photomultiplier (H9656-20; Hamamatsu
Photonics, Hamamatsu, Japan). Signals were amplified with a
lock-in amplifier (7230 DSP, Signal Recovery, Oak Ridge, TN,
USA) and recorded with a data acquisition pad (PCI-6221;
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National Instruments, Germany) and BioKine software
v. 4.49 (Bio-Logic). K8.6-HTF (in mM): 98.5 KCl, 0.2 MgSO4,
0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic
acid, 2.78 glucose, 21 N-[Tris(hydroxymethyl)methyl]-3-
aminopropanesulfonic acid (TAPS) and 4 KHCO3, pH 8.6 (ad-
justed with KOH). KCl-HTF (in mM): 98.5 KCl, 0.2 MgSO4,
0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic acid,
2.78 glucose, 21 HEPES and 4 KHCO3, pH 7.35 (adjusted with
KOH). pHo8.6-HTF (in mM): 93.8 NaCl, 4.69 KCl, 0.2 MgSO4,
0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic acid,
2.78 glucose, 21 TAPS and 4 NaHCO3, pH 8.6 (adjusted with
NaOH). Changes in Fluo-4 fluorescence are depicted as ΔF/F
(%), that is, the change in fluorescence (ΔF) relative to the
fluorescence (F) right after the mixing, to correct for intra-
and inter-experimental variations in basal fluorescence. For
single-cell Ca2+ imaging, sperm were incubated in the wells
of PLL-coated Greiner Cellview glass slides with Fluo-4-AM
(5 μM) for 30 min at 37°C, followed by another 15 min at
room temperature to allow settling of sperm on the glass sur-
face. Afterwards, the buffer was replaced twice with 90 μL of
‘fresh’ HTF to remove excess extracellular dye. Progesterone
and RU1968F1 were injected in a 1:10 dilution (10 μL) into
the well, and the ensuing changes in [Ca2+]i were observed
under an Olympus IX73 inverted microscope, equipped with
a 20×/0.75 objective (U Plan S Apo, Olympus, Germany),
coupled to an Andor Zyla 4.2 sCMOS camera (Andor Technol-
ogy, Belfast, UK). Images were captured at 1 Hz. Changes in
[Ca2+]i were determined from a region of interest around the
head and neck of single sperm. Signals are displayed as
(F-F0)/(Fmax-F0); F0 is the mean fluorescence of ≥5 images be-
fore injection of RU1968F1 or progesterone, whereas Fmax is
the peak fluorescence signal evoked by a subsequent injec-
tion of ionomycin. This procedure corrects for intra- and
inter-experimental variations in resting [Ca2+]i and dye load-
ing among individual sperm.
Inmouse sperm populations, changes in [Ca2+]i weremea-
sured in sperm loaded with Cal520-AM (5 μM) (ATT Bioquest,
USA) in the presence of Pluronic F-127 (0.02%w/v) for 45min
at 37°C in TYH buffer. After loading, excess dye was removed
by three centrifugations (700× g, 7 min, room temperature).
Recordings were performed using the stopped-flow apparatus
as described above, but with mixing at a flow rate of
0.5 mL·s1. K8.6-TYH (in mM): 4.8 NaCl, 138 KCl, 2 CaCl2,
1.2 KH2PO4, 1 MgSO4, 5.6 glucose, 0.5 Na-pyruvate, 10 lactic
acid, 10 TAPS, pH 8.6 (adjusted with KOH).
In sea urchin sperm populations, changes in [Ca2+]i were
recorded in Fluo4-loaded sperm. To this end, dry sperm
(diluted 1:6 (v/v)) were loaded with Fluo4-AM (10 μM) in
the presence of Pluronic F-127 (0.02% w/v) for 45 min at
18°C in ASW. After loading, sperm were diluted 1:20 (v/v) in
ASW and allowed to equilibrate for 5 min. Recordings were
performed using the stopped-flow apparatus with a flow rate
of 1 mL·s1. Fluorescence was excited, recorded, and proc-
essed as described above.
KCl-ASW (in mM): 216 KCl, 216 NaCl, 9.27 CaCl2, 22.94
MgCl2, 25.5 MgSO4, 0.1 EDTA, 10 HEPES, pH 7.8, (adjusted
with NaOH).
Patch-clamp recordings
Patch-clamp recordings from human sperm were performed
in the whole-cell configuration, as previously described
(Strünker et al., 2011). Seals between pipette and sperm were
formed either at the cytoplasmic droplet or the neck region
in standard extracellular solution (HS) containing (in mM):
135 NaCl, 5 KCl, 1 MgSO4, 2 CaCl2, 5 glucose, 1 Na-pyruvate,
10 lactic acid and 20 HEPES, pH 7.4 (adjusted with NaOH).
CatSper currents were recorded in divalent-free solutions
containing (in mM): 140 CsCl, 40 HEPES, 1 EGTA, pH 7.4 (ad-
justed with CsOH); the pipette solution contained (in mM):
130 Cs-aspartate, 50 HEPES, 5 EGTA, 5 CsCl, pH 7.3 (adjusted
with CsOH). Slo3 currents were recorded in HS with a pipette
solution containing (in mM): 140 K-aspartate, 50 HEPES, 10
NaCl, 5 KCl, 0.5 CaCl2, pH 7.3 (adjusted with KOH). Currents
carried byHv1 channelswere recorded in a bath and pipette
solution containing (in mM): 120 NMDG, 100 2-(N-
morpholino)ethanesulfonic acid (MES), 5 TEA-Cl, 2 EGTA,
pH 6 (adjusted with methanesulfonic acid). To depict mean
changes in CatSper currents, CatSper current amplitudes
were normalized to that of the monovalent currents in the
absence of any progesterone, NH4Cl or RU1068F1. This pro-
cedure corrects for variations in amplitudes among individ-
ual sperm to ease and to improve the clarity of the graphical
illustration. Patch-clamp recordings from mouse sperm were
performed in the whole-cell configuration, as previously de-
scribed (Kirichok et al., 2006; Zeng et al., 2011). Seals between
pipette and sperm were formed at the cytoplasmic droplet.
For Slo3 recordings, the extracellular solution contained (in
mM): 160 KOH, 10 HEPES, 150MES and 2 Ca(MES)2, adjusted
to pH 7.4 with MES; the pipette solution contained (in mM):
155 KOH, 5 KCl, 10 BAPTA, 20 HEPES, 115 MES, pH 8.0 (ad-
justed with KOH). CatSper currents were recorded in
divalent-free solutions containing (in mM): 150 NaCl, 20
HEPES, 5 EDTA, pH 7.4 (adjusted with NaOH); and with a pi-
pette solution containing (in mM) 135 Cs-MES, 10 HEPES, 10
EGTA and 5 CsCl, pH 7.2 (adjusted with CsOH). Current am-
plitudes were normalized to that of the monovalent currents
in the absence of NH4Cl or RU1968F1 (control) to correct for
variations in amplitudes among individual sperm.
Human T-type (Cav3.2) and L-type (CaV1.2 + β2b + α2δ1)
Ca2+ channels were studied in HEK293T cells (The European
Collection of Cell Cultures, Porton Down, UK) that were cul-
tured according to the supplier’s protocol in the presence of
penicillin G (100 U·mL1) and streptomycin (10 mg·mL1).
Cells were transfected at 40% confluency with pcDNA3.1-
CACNA1C, pcDNA3.1-CaVb2b and pIRES-dsRed-CaVa2d1
in a ratio of 2:1:1 μg, or with 2 μg of pCMV-Entry-CACNA1H,
using the calcium-phosphate precipitation method. Patch-
clamp recordings from HEK293T cells were performed in the
whole-cell configuration, using a HEKA EPC 10 amplifier with
PatchMaster software (both HEKA Elektronik, Lambrecht,
Germany). The extracellular solution contained (in mM):
125 TEA-Cl, 15 glucose, 10 HEPES, 5 CaCl2, pH 7.4, (adjusted
with CsOH); the pipette solution contained (in mM): 100
CsCl, 10 EGTA, 10 HEPES, 5 TEA-Cl, 5 MgATP, 0.2 NaGTP,
pH 7.4 (adjusted with CsOH). RU1968F1 was applied via a
gravity-driven perfusion system.
Analysis of sperm motility
To evaluate the acute action of RU1968F1 on motility param-
eters, sperm from a particular sample were incubated side-by-
side in HTF lacking NaHCO3 and HSA (non-capacitating
medium) and in capacitating medium (25 mM NaHCO3/
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3 mg·mL1 HSA). After 3 h of incubation at 37°C, sperm kine-
matic parameters were analysed by a CASA system (CEROS,
Hamilton Thorn Research, Beverly, MA, USA) before and after
application of RU1968F1. Sperm were bathed in RU1968F1
for 5 min prior to the experiment. To evaluate the long-term
action of RU1968F1 on sperm motility parameters, sperm
were re-suspended in capacitating medium (HTF containing
25 mM NaHCO3 and 3 mg·mL
1 HSA) with or without
RU1968F1. After 3 h of incubation at 37°C, sperm kinematic
parameters were analysed by CASA. To evaluate the action of
RU1968F1 on progesterone-induced hyperactivation, capaci-
tated spermwere incubated for 5min in the absence (control)
and presence of progesterone, RU1968F1, and progesterone
plus RU1968F1, and the motility was analysed by CASA. The
following parameters were determined by CASA: curvilinear
velocity (VCL, μm·s1), amplitude of lateral head displace-
ment (ALH, μm), linearity of progression (LIN, %), percentage
of total, progressive and rapidmotility as well as percentage of
motile, hyperactivated sperm. The threshold values for hyper-
activationweremanually set (VCL>150mm·s1,ALH>7mm,
LIN < 50% (Mortimer et al., 1998; Tamburrino et al., 2014). A
minimum of 100 cells and five fields of viewwere analysed for
each aliquot. The experiments were performed at 37°C.
Motility in human sperm evoked by uncaging of proges-
terone were studied in an observation chamber (100 μm
depth) under an Olympus IX71 inverted microscope
(Olympus, Tokyo, Japan), equipped with a 4× microscope ob-
jective (0.13 NA, UPLFLN-PH, Olympus) under dark-field illu-
mination [red light-emitting diode (LED), M660 L3-C1,
Thorlabs]. Movies were recorded at a total magnification of
6.4× with a high-speed CMOS camera (Dimax HD, PCO,
Kelheim, Germany) at 150 Hz. Photolysis of caged progester-
one (1 μM) (Kilic et al., 2009) was achieved using a 200 ms
light flash delivered by a 365 nm LED (M365 L2-C, Thorlabs,
Munich, Germany). Movies were processed and analysed
using a customized CASA plugin for ImageJ. Changes in the
velocity average path (VAP) are shown as VAP (%), that is,
the change in VAP relative to the VAP right before the UV
flash, to correct for intra- and inter-experimental variations
and for the different resting VAP in the absence and presence
of the inhibitor. This procedure eases and improves the clarity
of the graphical illustration.
Kremer penetration assays were performed in sEBSS
supplemented with methylcellulose (1% w/v) and 0.3%
BSA, equilibrated overnight at 4°C (penetration medium).
The penetration medium, with or without RU1968F1, was
filled into flattened glass capillary tubes (dimensions:
1.2 × 4.8 × 50 mm, 400 μm depth; CM scientific, UK); one
end of the tubes was sealed with CristaSeal wax (Hawksley,
UK). The open ends of the tubes were submersed in a sperm
suspension (3 × 106·mL1) with or without stimuli and/or
RU19868F1. Penetration was assessed after 1 h (37°C, 5.5%
CO2) by counting sperm at 2 cm using a phase contrast micro-
scope at a 200× magnification. Three fields of view were cho-
sen, and in each field, three focal planes were counted,
yielding nine fields altogether.
Human sperm viability and motility, as shown in
Supporting Information Figure S3, was tested following incu-
bation of sperm for 5 min at room temperature with
RU1968F1, NNC-55-0396, mibefradil or the vehicle (DMSO).
The fraction of immotile and dead sperm was assessed by
counting and by an eosin vitality test, respectively, at 200×
magnification under a phase-contrast microscope (Axiostar,
Carl Zeiss), in accordance with the WHO guidelines for se-
men analysis (WHO, 2010). For the eosin staining, 5 μL of
the sperm suspension was mixed with 5 μL of eosin staining
solution [0.5% (w/v) eosin Y dissolved in a 0.9% NaCl solu-
tion] on amicroscope slide, covered with a 22 × 22mm cover-
slip and incubated for 30 s at RT. Eosin-positive (dead) versus
eosin-negative (live) sperm were counted. To determine the
fraction of immotile and viable sperm, a total number of
400 sperm were assessed.
Sea urchin sperm chemotaxis was studied as described
(Seifert et al., 2015). In brief, sperm (~108 cells·mL1) were ob-
served in a recording chamber (150 μm depth) under an IX71
microscope (Olympus), equipped with a 10× microscope ob-
jective (UPlanSApo; NA 0.4; Olympus), with stroboscopic
(500 Hz) dark-field illumination (white LED; K2 star;
Luxeon). Movies were recorded with an EMCCD camera
(DU-897D; Andor) at 20 Hz through a bandpass filter
(HQ520/40; Chroma). Photolysis of caged resact was
achieved using a 200 ms pulse from a 365 nm LED
(M365 L2-C, Thorlabs). The relative dispersion was calculated
as described before (Seifert et al., 2015).
Acrosomal exocytosis
Human sperm, capacitated for at least 300 min, were incu-
bated with either 0.1% DMSO (vehicle control), RU1968F1
(10 μM), progesterone (10 μM) or a mixture of both (10 μM
each) for 1 h at 37°C. Afterwards, sperm were washed by cen-
trifugation and re-suspended in 0.5 mL of hypo-osmotic
swelling medium (WHO, 2010). After 1 h at 37°C, sperm were
washed again and fixed in 50 μL ice-cold methanol. The
sperm were layered on a slide, air-dried, and stored at
20°C. For acrosome staining, sperm were incubated for
20 min in the dark with 1 mg·mL1 FITC-labelled Arachis
hypogaea (peanut) lectin (PNA-FITC, Sigma Aldrich) in PBS.
Slides were analysed using an Axiolab A1 FL microscope (Carl
Zeiss, Jena, Germany). For each condition, 200 curled-tail (vi-
able) cells were analysed for their acrosomal status, as previ-
ously described (Tamburrino et al., 2014).
Data analysis and statistical evaluation
The data and statistical analysis comply with the recommen-
dations on experimental design and analysis in pharmacol-
ogy (Curtis et al., 2018). Experiments and data analysis were
performed without randomization and blinding, except for
the Eosin test and the manual counting of motile/immotile
sperm. Otherwise, non-treated and treated conditions were
measured and analysed side-by-side by the same experi-
menter, using objective measures and analysis methods.
All data are presented as mean ± SD. Statistical analysis
and fitting of dose–response relations were performed using
GraphPad Prism 5 (Prism, La Jolla, USA). Half-maximal inhib-
itory concentrations (IC50) were derived by nonlinear regres-
sion analysis, using a four parameter fit:
Y ¼ bottomþ top bottomð Þ
1þ 10 logIC50xð Þn
  :
Y = signal amplitude; bottom and top = plateaus in the units
of Y; x = log(concentration of inhibitor); IC50 = concentration
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of agonist that gives the response half way between bottom
and top; n = Hill coefficient.
Most of the experiments were performed in a randomized
block design, that is, for each experimental replicate, sperm
prepared from one particular semen sample were subjected
in parallel to all treatment conditions. If the experiment in-
volved two conditions (control and treatment), we used the
paired t-test. If the experiment involved ≥3 conditions, we
used one-way randomized block ANOVA, assuming spheric-
ity. When ANOVA’s F-test and the test for matching efficacy
achieved P < 0.05, means were compared to the control’s
mean by Dunnett’s multiple comparisons post hoc test, unless
otherwise indicated. If experiments were not performed in a
randomized block design, we used unpaired t-test or one-
way ANOVA; when ANOVA’s F-test achieved P < 0.05 and
Bartlett’s test yielded no significant variance inhomogeneity,
means were compared to the control’s mean or to each other
by Dunnett’s or Bonferron’s multiple comparisons post hoc
test respectively. In Figures 6E, J, and 8I, for the ease of
illustration and for clarity, we show data normalized to the
control. We normalized the data only after the statistical
analysis using one-way ANOVA, because normalization
makes any data set violate the ANOVA.
Materials
The suppliers of the compounds used in these experiments are
as follows: progesterone from Sigma and the caged form was
prepared as described by Kilic et al., 2009; 8-Br-cAMPwas from
BioLog (Bremen, Germany); resact and its caged form were
prepared as described by Böhmer et al., 2005 and Kaupp
et al., 2003; mibefradil, MDL12330A, NNC-0396 and PGE1
were supplied by Tocris (Wiesbaden-Nordenstadt, Germany).
Nomenclature of targets and ligands
Key protein targets and ligands in this article are
hyperlinked to corresponding entries in http://www.
guidetopharmacology.org, the common portal for data from
the IUPHAR/BPS Guide to PHARMACOLOGY (Harding
et al., 2018), and are permanently archived in the Concise
Guide to PHARMACOLOGY 2017/18 (Alexander et al.,
2017a,b).
Results
Synthesis of RU1968
We synthesized RU1968 from (±) estrone methyl ether
(Figure 1A and Supporting Information Figure S1) that is read-
ily accessible via the Torgov route (Ananchenko et al., 1962;
Ananchenko and Torgov, 1963). Van Leusen reaction yielded
the nitrile (1) (Van Leusen and Van Leusen, 2004), followed
by addition of methyllithium to yield the ketone (2).
Reductive amination with N,N-dimethylethylenediamine
established the aza side chain, yielding a mixture of four dia-
stereomers (3) (at C-17 and C-20; Figures 1A compound 3).
We separated two diastereomers (Figure 1A, compounds 3a
and 3b), each a mixture of a cis and a trans isomer. Relative
configurations [C-18 (CH3) and C-20 (CH)] were assigned by
NMR spectroscopy (H,H-COSY and NOE, Supporting Infor-
mation Figures S1 and S2); the cis isomers were the dominant
species (cis/trans ratio for compound 3a was 3:1; and for 3b, it
was 4:1). Finally, cleavage of the phenolic methyl ether
yielded a diastereomeric mixture of RU1968. The diastereo-
mers eluted from a preparative HPLC in four fractions called
RU1968F1-4; RU1968F1 and 2 are derived from 3a cis and
trans, respectively, whereas RU1968F3 and 4 are derived from
3b trans and cis, respectively (Figure 1C). Because the actions
of RU1968F2-4 in spermwere similar to that of RU1968F1 (see
Figure 2 and Supporting Information Figures S3 and S6), we
chose RU1968F1 to characterize its action in sperm. We first
examined the action of RU1968F1 in populations of human
sperm loaded with a fluorescent pHi or Ca
2+ indicator
Figure 1
Synthesis of RU1968F1-F4. (A) Synthesis of RU1968. Carbon atoms referred to in the text are marked with circles. (B) Structure of RU1968.
(C) HPLC-elution profile of the four diastereomers. Isomers are named according to their order of elution.
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(Supporting Information Figure S3A–D). The drug evoked
negligible changes in pHi. At concentrations ≤7.5 μM,
RU1968F1 caused a small, transient Ca2+ increase; [Ca2+]i
peaked and returned to basal levels within about 250 s. At
concentrations >7.5 μM, RU1968F1 evoked a slow decrease
of [Ca2+]i. The mechanism(s) underlying the drug-evoked
changes in [Ca2+]i are unclear. In the absence of extracellular
Ca2+, the drug did not change [Ca2+]i, indicating that Ca
2+
release from internal stores is not involved (Supporting
Information Figure S3C). Most importantly, even at high
micromolar concentrations (30 μM), the drug did not
affect overall human sperm motility and viability and did
not evoke acrosomal exocytosis (Supporting Information
Figure S3E–G). Thus, RU1968F1 lacks the toxic and adverse
actions of NNC-0396, mibefradil, and MDL12330A in human
sperm.
RU1968F1 is a potent cross-species inhibitor of
CatSper channels
To investigate whether RU1968F1 inhibits human CatSper
channels, we studied progesterone- and PGE1-evoked Ca
2+
signals in human sperm in the presence of RU1968F1.
RU1968F1 slowed down and completely suppressed the
Ca2+ signals in a dose-dependent fashion. The IC50 values of
4 ± 2 μM (progesterone) and 3.8 ± 0.5 μM (PGE1) (n = 7, mean-
± SD)were similar to those reported previously (Schaeferet al.,
2000) (Figure 2A–D). The compound was effective within a
range of extracellular pH (pHo) values: at pHo 6.8 and 7.8,
the IC50 value of the progesterone-evoked Ca
2+ signal was
4.4 ± 1.4 and 2.2 ± 0.6 μM, respectively (n = 6) (Figure 2B).
The actions of RU1968F2-4 alone and on progesterone-
evoked Ca2+ signals were similar to those of RU1968F1 (see
Figure 2 and Supporting Information Figures S3 and S6).
Figure 2
Action of RU1968F1 on CatSper-mediated Ca2+ signals in human sperm populations. (A) Progesterone-evoked Ca2+ signals in human sperm in the
absence and presence of RU1968F1. ΔF/F (%) indicates the percentage change in fluorescence (ΔF) with respect to the mean basal fluorescence
(F) before application of progesterone (500 nM). (B) Dose–response relation for the maximal signal amplitudes of the data from (A) (pH 7.35)
(IC50 = 5.5 μM) and of progesterone responses studied at an extracellular pH of 6.8 (IC50 = 4.2 μM) or 7.8 (IC50 = 2.6 μM). (C) PGE1-evoked
Ca2+ signals in human sperm in the absence and presence of RU1968F1; PGE1 = 500 nM. (D) Dose–response relation for the maximal signal
amplitudes of the data from (C) (IC50 = 3.1 μM). (E) NH4Cl-evoked Ca
2+ signals in the absence and presence of RU1968F1, NH4Cl = 3 mM. (F)
Dose–response relation for the maximal signal amplitude of the data from (E) (IC50 = 1.8 μM) (G) Ca
2+ signals evoked by various NH4Cl
concentrations in the absence (control) and presence of RU1968F1 (30 μM). (H) Mean relative amplitude of Ca2+ signals evoked by various NH4Cl
concentrations in the presence of RU1968F1 (30 μM) (n = 5); amplitude evoked in the absence of RU1968F1 = 1 (control). Data shown are means
± SD. *P < 0.05, significantly different from control. (I) Ca2+ signals evoked by simultaneous mixing of sperm with progesterone (500 nM) and
RU1968F1 in a stopped-flow apparatus. ΔF/F (%) indicates the percentage change in fluorescence (ΔF) with respect to the fluorescence (F)
immediately after mixing. (J) Dose–response relation of the data from (I) (IC50 = 2.4 μM). (K) Ca
2+ signals evoked by mixing of sperm with
K8.6-HTF and RU1968F1. The final K+ concentration and pH after mixing was 51.25 mM and 8.1 respectively. (L) Dose–response relation of
the data from (K) (IC50 = 1.7 μM).
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Furthermore, we studied whether RU1968F1 also inhibits
Ca2+ signals evoked by intracellular alkalization via the weak
base NH4Cl (Figure 2E–H). The compound slowed down and
almost completely suppressed Ca2+ signals evoked by
NH4Cl ≤ 3 mM (Figure 2E, F); the IC50 value for 3 mM NH4Cl
was 4.0 ± 2.8 μM (n = 5) (Figure 2F, G). Ca2+ signals evoked by
10 mM NH4Cl were only slightly attenuated, whereas for
30 mM NH4Cl, the signal was rather similar in the absence
and presence of RU1968F1 (Figure 2G, H). We conclude
that RU1968F1 inhibits also ΔpHi-evoked Ca
2+ responses.
However, its potency seems to decrease with increasing ΔpHi.
Alternatively, the presence of NH4
+ or NH3 might impair
binding of RU1968F1 to its blocking site. Arguing against that
notion, the compound readily suppressed progesterone
responses in sperm that were bathed for about 20 min in
NH4Cl (30 mM) (Supporting Information Figure S5;
IC50 = 3.5 ± 1.4 μM, n = 3); with time, the pHi slowly recovers
from the NH4Cl-evoked alkalization (Strünker et al., 2011).
Influx of Ca2+ via CatSper can also be evoked by
simultaneous extracellular alkalization (which increases pHi)
and depolarization by K+ (K8.6 buffer) (see Carlson et al., 2003).
RU1968F1 suppressed Ca2+ signals evoked by simultaneous
alkalization/depolarization (Figure 2K, L; IC50 = 1.2 ± 0.6 μM,
n = 3) and by alkalization or depolarization alone (Supporting
Information Figure S4). Finally, when sperm were mixed simul-
taneously with progesterone and RU1968F1 in a stopped-flow
apparatus, the inhibition of Ca2+ responses was similar to that
underpre-incubationconditions(Figure2I, J) (IC50=3.0±1.1μM;
n = 4). This result suggests that RU1968F1 rapidly reaches its
blocking site.
Next, we studied the action of RU1968F1 in single human
sperm by Ca2+ imaging. At concentrations ≥10 μM, RU1969F1
evoked a slow decrease of [Ca2+]i (Figure 3A). For low micro-
molar RU1969F1 concentrations, we did not observe Ca2+
transients, which might reflect differences in sensitivity of
population versus single-cell fluorimetry. In the presence of
RU1968F1, progesterone-induced Ca2+ responses were sup-
pressed in a dose-dependent fashion (Figure 3B–D) with an
IC50 of 4.8 ± 1.2 μM (standard error of the fit). Altogether,
the action of the RU1868F1 itself on [Ca2+]i and on
progesterone-evoked Ca2+ responses is similar when investi-
gated in sperm populations and in single sperm.
We further tested whether the compound also inhibited
Ca2+ influx via CatSper channels in mouse sperm. Mouse
CatSper is insensitive to progesterone and PGs (Lishko et al.,
2011). Therefore, we activated CatSper via simultaneous
alkalization/depolarization or via 8-Br-cAMP, which activates
mouse (Ren et al., 2001) and human (Brenker et al., 2012)
CatSper at high concentrations. RU1968F1 suppressed Ca2+
responses evokedby alkalization/depolarizationor 8-Br-cAMP
with an IC50 of 0.83 ± 0.07 and 0.84 ± 0.03 μM respectively
(n = 3) (Figure 4A–D).
Figure 3
Action of RU1968F1 on progesterone-evoked Ca2+ signals in single human sperm. (A) Changes in [Ca2+]i evoked by RU1968F1 in immobilized
sperm. Sperm were challenged with RU1968F1 at t = 0. Traces represent averages of 122 (RU1968F1, 0 μM), 344 (1 μM), 42, (3 μM), 165
(10 μM) and 109 (30 μM) sperm from three donors. Signals are displayed as (F-F0)/(Fmax-F0); F0 is the mean fluorescence of ≥5 images before
application of RU1968F1; Fmax is the peak fluorescence signal evoked by ionomycin (not shown) to gauge the maximal response amplitude.
(B) Progesterone-evoked Ca2+ responses (2 μM) in the absence and presence of RU1968F1 (30 μM); averages of 50 (control) and 109
(RU1968F1) sperm from three donors. Progesterone and RU1968F1 were applied at t = 0; following application of RU1968F1, progesterone
was applied at the time point indicated by the arrow. (C) Amplitude of progesterone-evoked Ca2+ responses in the absence and presence of
different RU1968F1 concentrations; averages of 122 (RU1968F1, 0 μM), 344 (1 μM), 42 (3 μM), 165 (10 μM) and 109 (30 μM) sperm from three
donors. (D) Mean amplitude of progesterone-evoked Ca2+ signals (2 μM) in the presence of RU1968F1; number of sperm: 310 (RU1968F1, 0 μM),
552 (1 μM), 181 (3 μM), 302 (10 μM) and 222 (30 μM). Data shown are means ± SD. Fitting of a dose–response curve to the data yielded an IC50
of 4.8 ± 1.2 μM (standard error of the fit).
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Finally, we investigated the action of RU1968F1 on
CatSper in sperm of the sea urchin A. punctulata. To this
end, we studied CatSper-mediated Ca2+ responses evoked
either by the chemoattractant resact, depolarization of Vm,
or by NH4Cl. Irrespective of the stimulus, RU1986F1
suppressed the Ca2+ responses with IC50 values of 1.3 ± 0.1,
1.1 ± 0.4 and 4 ± 2 respectively (n = 3) (Figure 5A–F). Alto-
gether, these results suggest that RU1968F1 is a potent cross-
species CatSper inhibitor.
To scrutinize this conclusion by an independent tech-
nique, we recorded CatSper currents in human and mouse
sperm by whole-cell patch clamping. In human sperm,
monovalent CatSper currents were evoked by stepping the
membrane voltage from 100 to +150 mV in increments of
10 mV from a holding potential of 0 mV. RU1968F1
completely suppressed these currents with an IC50 of
0.4 ± 0.3 μM (n = 5) (Figure 6A, B). Superfusion with progester-
one or NH4Cl enhanced the current amplitudes (Figure 6C,
D). The progesterone- and NH4Cl-evoked currents were either
completely suppressed or strongly attenuated by RU1968F1
(Figure 6C–E). In mouse sperm, monovalent CatSper currents
were evoked by ramping the membrane voltage between
100 and +100 mV from a holding potential of 0 mV.
Superfusion with RU1968F1 completely suppressed the cur-
rents with an IC50 of 10 ± 1 μM (Figure 6F, G). CatSper cur-
rents evoked at pHi 8 and by NH4Cl were strongly
attenuated by the drug (Figure 6H–J). Thus, RU1968F1 in-
hibits human and mouse CatSper at rest and upon activation
by ligands and ΔpHi. Similar to the results obtained by Ca
2+
fluorimetry, the potency of the drug decreased with increas-
ing pHi. We did not test whether higher RU1968F1 concen-
trations completely suppress the currents evoked by NH4Cl
and at pHi 8.
RU1968F1 inhibits human but not mouse Slo3
channels
We studied the interaction of RU1968F1 with sperm ion
channels other than CatSper. In mouse sperm, currents car-
ried by the K+ channel Slo3 were similar in the absence and
presence of RU1968F1 (Figure 7A, B). By contrast, in human
sperm, the Slo3 current was inhibited with an IC50 of
7 ± 6 μM (n = 4) (Figure 7C, D). Thus, although not completely
selective for CatSper, about 15-fold higher RU1968F1 concen-
trations were required to block human Slo3. At concentra-
tions up to 10 μM, the compound did not inhibit the
voltage-gated proton channel Hv1 and the ATP-gated P2X
channel (Supporting Information Figure S7), which are
expressed in human and mouse sperm, respectively (Lishko
et al., 2010; Navarro et al., 2011). We conclude that in mouse
sperm, RU1968F1 acts rather selectively on CatSper. In
human sperm, the compound also inhibited Slo3, but with
about 15-fold lower potency. Finally, RU1968F1 inhibited
heterologously expressed L- and T-type Ca2+ channels with
IC50 values of about 20 and 10 μM, respectively (Supporting
Information Figures S9 and S10), indicating that the com-
pound also acts with lower potency on classic voltage-gated
Ca2+ channels of somatic cells.
RU19681F1 suppresses progesterone-evoked
motility responses in human sperm
Next, we tested the action of RU1968F1 on themotility of hu-
man sperm using CASA. A brief incubation (5 min) of non-
capacitated or capacitated sperm with the compound did
not impair overall motility (Figure 8A, B), whereas the frac-
tion of progressively motile sperm decreased about twofold
with increasing RU1968F1 concentrations (Figure 8A, B).
Whether this is due to the inhibition of CatSper channels or
represents an adverse action of the drug is unclear.
Furthermore, the penetration of the egg coat requires
hyperactivated motility, which is characterized by an asym-
metric flagellar beat, lower beating frequency, wiggly swim-
ming trajectory and lower VAP (Suarez, 2008). In mouse
sperm, CatSper channels are required for hyperactivation
(Ren et al., 2001), whereas the control of hyperactivation by
CatSper in human sperm is debated (Alasmari et al., 2013b;
Tamburrino et al., 2014). We studied whether RU1968F1 af-
fects hyperactivation in human sperm. A brief incubation
(5min) of capacitated spermwith RU1968F1 did not suppress
spontaneous hyperactivated swimming. In fact, RU1968F1
concentrations <10 μM seem to slightly enhance hyperacti-
vation, whereas higher concentrations had no effect
(Figure 8B). Spontaneous hyperactivation develops during
the capacitation process (compare Figure 8A, B). In sperm
that were capacitated in the presence of RU1968F1 (10 μM),
that is, incubated for some hours under capacitating condi-
tions, the compound suppressed spontaneous hyperactiva-
tion (Figure 8C), while the fraction of progressively motile
sperm or overall motility was not affected (Figure 8D, E). This
result suggests that, in human sperm, CatSper channels are
involved in the ability to undergo hyperactivation; though,
Figure 4
Action of RU1968F1 on CatSper-mediated Ca2+ signals in mouse sperm populations. (A) Ca2+ signals evoked by simultaneous mixing of mouse
sperm with K8.6-TYH and RU1968F1 in a stopped-flow apparatus. After mixing, the final K+ concentration and pH was 69 mM and 8.1 respec-
tively. (B) Dose–response relation of the data from (A) (IC50 = 0.90 μM). (C) Ca
2+ signals evoked by simultaneous mixing of mouse sperm with
8-Br-cAMP (20 mM) and RU1968F1. (D) Dose–response relation of the data from (C) (IC50 = 0.84 μM).
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the partial inhibition of Slo3 might contribute to this action
of RU1968F1.
Finally, we studied the action of RU1968F1 on
progesterone-induced changes in swimming behaviour. Incu-
bation of capacitated sperm with progesterone seemingly
promoted hyperactivation, which was inhibited by
RU1968F1 (Figure 8F); the effect of progesterone was, how-
ever, not statistically significant. Therefore, we studied the
motility of human sperm before and after rapid activation
of CatSper, using caged progesterone (Kilic et al., 2009).
Uncaging of progesterone by a brief (200 ms) UV flash
instantaneously evoked a wiggly swimming trajectory
(Figure 8G) and a decrease of VAP (Figure 8G, I), resembling
hyperactivated motility. The VAP reached its minimum ~5 s
after uncaging of progesterone and did not recover within
the recording time of 10 s. In the presence of RU1968F1, the
swimming trajectory and the swimming pattern and VAP
remained unchanged upon uncaging of progesterone
(Figure 8H, I). We conclude that progesterone-evoked hyper-
activation requires Ca2+ influx via CatSper.
Furthermore, it is well established that progesterone facili-
tates the migration of human sperm into viscous medium
(Alasmari et al., 2013b). In human sperm lacking functional
CatSper channels, this facilitation was abolished (Williams
et al., 2015). Using a modified Kremer’s sperm-mucus penetra-
tion test, we investigated whether inhibition of CatSper by
RU1968F1 reproduced this phenotype. To this end, an open
glass capillary, which contained medium fortified with methyl-
cellulose, was immersed in a sperm suspension and the num-
ber of sperm at a penetration distance of 2 cm (Figure 9A–C)
was determined. Data for shorter or longer penetration dis-
tances are presented in Supporting Information Figure S8. Con-
sistent with previous results (Alasmari et al., 2013b), bathing
sperm in progesterone enhanced the number of sperm
Figure 5
Action of RU1968F1 on Ca2+ responses mediated by CatSper channels in sea urchin sperm. (A) Resact-induced Ca2+ signals in sea urchin sperm
evoked by simultaneous mixing of sperm with resact (20 pM) and RU1968F1 in a stopped-flow apparatus. (B) Dose–response relation of the data
from (A) (IC50 = 0.7 μM). (C) Depolarization-induced Ca
2+ signals evoked by mixing of sperm with KCl-ASW and RU1968F1. Final K+ concentra-
tion after mixing was 108mM. (D) Dose–response relation of the data from (C) (IC50 = 1.0 μM). (E) Alkaline-evoked Ca
2+ signals in the presence of
RU1968F1; the final NH4Cl concentration after mixing was 30 mM. (F) Dose–response relation of the data from (E) (IC50 = 4.6 μM).
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penetrating the viscous medium (Figure 9A, C, and Supporting
Information Figure S8A, C). The effects of progesterone were
abolished by 1 μM RU1968F1 (Figure 9A and Supporting Infor-
mation Figure S8A). Of note, at this concentration, the drug it-
self did not affect the number of penetrating cells (Figure 9B
and Supporting Information Figure S8B). These effects of pro-
gesterone were also abolished when RU1968F1 was added to
the capillary medium instead of to the sperm suspension
(Figure 9C and Supporting Information Figure S8C). These re-
sults support the notion that progesterone acts via CatSper to
promote swimming in high-viscosity media and shows that
RU1968F1 mimics the lack of functional CatSper channels. Of
note, at concentrations >1 μM, RU1968F1 in a dose-dependent
fashion lowered the number of penetrating sperm both in the
absence and presence of progesterone (Figure 9A, B, and
Supporting Information Figure S8A, B). This probably reflects
the compound-related decrease of the fraction of progressively
motile sperm.
Incubation of human sperm in high micromolar
concentrations of progesterone evokes acrosomal exocytosis
(Baldi et al., 2009) (Figure 9D), that is, the release of proteo-
lytic enzymes from a secretory vesicle in the sperm head. In
the presence of RU1968F1, this action of progesterone was
attenuated (Figure 9D), whereas RU1968F1 itself did not
evoke acrosomal exocytosis (Figure 9D and Supporting
Information Figure S3). These results suggest that the
progesterone-induced acrosome reaction involves Ca2+
influx via CatSper and that RU1968F1 might allow the
elucidation of the role of CatSper in this process in more
detail. Altogether, we conclude that RU1968F1 can provide
important insight on the role of progesterone action on
CatSper to control sperm function.
Figure 6
RU1968F1 inhibits monovalent cation currents carried by CatSper channels in human and mouse sperm. (A) Representative current–voltage
relationship of CatSper currents recorded from a human sperm cell in divalent-free extracellular and intracellular solution (pH 7.4) in the absence
and presence of increasing RU1968F1 concentrations. Voltage was stepped from 100 to +150 mV in increments of 10 mV. Inset: Voltage
protocol. (B) Dose–response relation for the inhibition of human CatSper currents by RU1968F1 at +100 mV (IC50 = 0.4 ± 0.3 μM; n = 5). (C)
Representative monovalent CatSper currents recorded from a human sperm cell before (control) and after perfusion with progesterone (2 μM)
and progesterone plus RU1968F1 (3 μM), evoked by the voltage protocol shown in (A). The dotted red line indicates the current at 0 mV. (D)
Monovalent CatSper currents recorded from a human sperm cell before (control) and after perfusion with NH4Cl (10 mM) and NH4Cl plus
RU1968F1 (3 μM), evoked by the voltage protocol shown in (A). The dotted red line indicates the current at 0 mV. (E) Mean amplitudes of mono-
valent currents at +100 mV recorded in the presence of RU1968F1, progesterone (2 μM), progesterone plus RU1968F1, NH4Cl (10 mM), and
NH4Cl plus RU1968F1. Amplitudes were normalized to that evoked in the absence of any drug (control, dashed line). Data shown are means ±
SD (n = 5). *P < 0.05, significantly different from control. Data were normalized only after performing the statistical analysis using one-way
ANOVA (see Methods for details and explanations). (F) Representative CatSper currents recorded from a mouse sperm cell in divalent-free extra-
cellular and intracellular solution (pH 7.2) in the absence and presence of increasing RU1968F1 concentrations. Voltage was ramped between
100 and +100 mV from a holding potential of 0 mV. Inset: Voltage protocol. (G) Dose–response relation for the inhibition of mouse CatSper
currents at +100 mV (IC50 = 10 ± 1 μM, n = 3). Data shown are means ± SD. (H) Currents in the presence of extracellular divalent ions (HS)
and monovalent currents in divalent-free conditions (control) recorded from a mouse sperm cell evoked at pHi 8 before (control) and after per-
fusion with RU1968F1, using the voltage protocol shown in (F). (I) Currents recorded from amouse sperm cell at pHi 7.2 before (control) and after
perfusion with NH4Cl (30mM) andNH4Cl plus RU1968F1, using the voltage protocol shown in (F). (J) Mean amplitudes of monovalent currents at
+100 mV recorded from mouse sperm in the presence of RU1968F1, NH4Cl plus RU1968F1, and at pHi 8 in the presence of RU1968F1, using the
voltage protocol shown in (F). Amplitudes were normalized to the monovalent currents evoked in the absence of any drug (control, dashed line).
Data shown are means ± SD (n = 5). *P< 0.05, significantly different from control. Data were normalized only after performing the statistical anal-
ysis using one-way ANOVA (see Methods for details and explanations).
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RU19681F1 inhibits chemotaxis of sea urchin
sperm
Finally, we tested whether RU1968F1 affected the CatSper-
mediated chemotactic steering of sea urchin sperm. In a
shallow observation chamber under a dark-field microscope,
sperm were bathed in a caged derivative of the
chemoattractant resact (Kaupp et al., 2003; Böhmer et al.,
2005; Alvarez et al., 2012). A chemoattractant gradient was
established by photolysis of caged resact via a UV flash in the
centre of the recording chamber (Figure 10A). After the flash,
sperm accumulated in the irradiated area, indicated by a de-
crease of sperm dispersion in the field of view (Figure 10B).
Such accumulation was abolished by RU1968F1 (Figure 10),
without affecting the overall motility of the sperm.
Discussion
Here, we introduce RU1968F1 as a new pharmacological tool
to elucidate the presence and role of CatSper channels in
sperm. RU1968F1 is superior to previously known inhibitors:
the compound is relatively selective for CatSper and lacks
toxic side effects in human sperm. However, because the ac-
tion of the compound is complex, we cannot exclude adverse
actions in other sperm species. This cautious note has to be
considered in futher studies of RU1968F1.
What is the molecular mechanism underlying inhibition
of CatSper by RU1968F1? It has been proposed that
progesterone acts via an endocannabinoid-signalling
pathway, involving the receptor α/β hydrolase domain-
containing protein 2 (ABHD2) (Miller et al., 2016). At rest,
CatSper is inhibited by the endocannabinoid
2-arachidonoylglycerol (2-AG) in the flagellar mem-
brane. Upon progesterone binding, ABHD2 degrades 2-AG
and, thereby, relieves CatSper from inhibition (Miller et al.,
2016). Considering that RU1968F1 is a steroid, this com-
pound might act as an antagonist at the steroid-binding site
on ABHD2. However, CatSper channel activation by PGs does
not involve ABHD2 (Miller et al., 2016), and in mouse and sea
urchin sperm, CatSper channels are not activated by proges-
terone or PGs (Lishko et al., 2011; Seifert et al., 2015). More-
over, activation of CatSper channels by alkaline pHi and
depolarization does probably not involve a ligand-binding
site. Therefore, we suspect that RU1968F1 binds to residues
in the pore region and, thereby, directly block ion flux. The
inhibitory action of this compound on classical voltage-gated
Ca2+ channels also supports this conclusion. Of note, the po-
tency of RU1968F1 to inhibit activation of CatSper channels
by alkalization seems to decrease with increasing amplitude
of ΔpHi. This might reflect a pH sensitivity of the blocking
mechanism or pH-dependent distribution of RU1968F1
across membranes. The latter is rather unlikely. Upon rapid
mixing, the compound blocks Ca2+ influx through CatSper
without a measurable latency, suggesting that the compound
is more likely to act from the outside. However, the mecha-
nism of CatSper channel inhibition will be difficult to
Figure 7
RU1968F1 inhibits human but not mouse Slo3 channels. (A) Representative Slo3 currents in a mouse sperm cell, recorded in the presence of ex-
tracellular divalent ions at symmetric intra- and extracellular K+ concentrations in the absence and presence of 50 μM RU1968F1. Inset: Voltage
protocol. (B) Mean Slo3 currents in mouse sperm at +100 mV in the absence and presence of 50 μM RU1968F1 (n = 5). (C) Representative Slo3
currents recorded from a human sperm cell in the absence and presence of RU1968F1. Inset: Voltage protocol. (D) Dose–response relation for the
inhibition of human Slo3 currents by RU1968F1 at +100 mV (IC50 = 7 ± 6 μM, n = 4). Data shown are means ± SD.
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elucidate rigorously by structure–function analysis or site-
directed mutagenesis, because CatSper channels resist func-
tional expression.
What is the nature of the blocking site in Slo3 in human
sperm? Human, but not mouse Slo3 channels, are inhibited
by micromolar concentrations of progesterone (Brenker
et al., 2014). This inhibition results from binding of progester-
one either to a site on the channel itself or on its accessory
subunit LRRC52 (Brenker et al., 2014). RU1968F1 might act
via this steroid-binding site on human Slo3. To improve the
selectivity of RU1968F1, a structure–activity analysis is re-
quired to identify derivatives that do not act on human
Slo3, but display a similar or even enhanced potency to in-
hibit CatSper. The fact that human Slo3 can be functionally
expressed in cultured cells (Brenker et al., 2014) facilitates this
endeavour.
Although the make-up of Ca2+-signalling pathways in
sperm is quite diverse (Kaupp and Strünker, 2016; Alvarez,
2017), the CatSper channel is a common component in
many, but not all species (Cai et al., 2014). Our finding that
RU1968F1 inhibits CatSper across species opens the
possibility to use the compound in a variety of experimen-
tal settings. First, teleost fish seem to lack CatSper genes
(Cai and Clapham, 2008), although the swimming
behaviour of zebrafish is controlled by Ca2+ (Fechner et al.,
2015). However, the absence of CatSper channels in fish
has been contested (Yanagimachi et al., 2017). RU1968F1
might help to solve this controversy. Second, the genome
Figure 8
RU1968F1 interferes with hyperactivation and abolishes progesterone-induced motility responses in human sperm. (A, B) Motility parameters of
non-capacitated (A) and capacitated (B) human sperm in the absence and presence of RU1968F1 (n = 8); spermwere bathed in the drug for 300 s.
Data shown are means ± SD. *P < 0.05, significantly different from control (absence of RU1968F1). (C–E) Fraction of hyperactivated (C), motile
(D), and progressively swimming (E) sperm after capacitation in the absence and presence of RU1968F1 (n = 11). Data shown are means ± SD.
*P < 0.05, significantly different from control (absence of RU1968F1). (F) Hyperactivation evoked by bathing sperm for 300 s in RU1968F1, pro-
gesterone, or progesterone plus RU1968F (n = 11). Data shown are means ± SD. (G) Track of a single sperm cell recorded before (3 s), during
(0.2 s) and after (2.8 s) uncaging of progesterone. The arrow indicates the direction of movement. Inset: time course of the VAP; the red bar in-
dicates the uncaging of progesterone. (H) Track of a single sperm cell recorded before (3 s), during (0.2 s, flash), and after (2.8 s) uncaging of
progesterone in the presence of RU1968F1 (30 μM). Inset: time course of VAP; the red bar indicates the uncaging of progesterone. (I) Mean rel-
ative changes in VAP averaged over 20–30 sperm in the field of view after uncaging of progesterone (n = 11). Data shown are means ± SD.
*P < 0.05, significantly different from control (before flash, 0 s). Data were normalized only after performing the statistical analysis using one-
way ANOVA (see Methods for details and explanations).
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Figure 9
RU1968F1 suppresses penetration of sperm into viscous media. (A) Number of sperm at a penetration distance of 2 cm in a modified Kremer’s
sperm–mucus penetration test. The spermwere incubated in buffer (control), progesterone, or progesterone plus RU1968F1 (n = 21). Data shown
are means ± SD. *P < 0.05, significantly different from control; #P < 0.05, significantly different from progesterone without RU1968F1. (B) Num-
ber of sperm after incubation in buffer (control) or RU1968F1 (n = 21). Data shown are means ± SD. *P < 0.05, significantly different from control
(n = 21). (C) Number of spermwhen the spermwere bathed in buffer (control) or progesterone, in the absence (0) or presence of RU1968F1 in the
capillary (n = 6). Data shown are means ± SD. *P < 0.05, significantly different from control; #P < 0.05, significantly different from progesterone
without RU1968F1. (D) Acrosome reaction evoked by RU1968F1, progesterone, or progesterone and RU1968F1 (n = 10). Data shown are means
± SD. *P < 0.05, significantly different from control, #P < 0.05, significantly different from progesterone.
Figure 10
RU1968F1 abolishes chemotaxis of sea urchin sperm. (A) Dark-field microscopy images of a sperm suspension before (top) and after (bottom) es-
tablishing a resact gradient by photolysis of caged resact (middle) in the absence (control, left panel) or presence of RU1968F1 (30 μM, right
panel). RU1968F1 abolishes resact-induced sperm accumulation. (B) Relative change of the sperm dispersion in the field of view evoked by
uncaging of resact (t = 0, flash) in the absence (control) or presence of RU1968F1; a decrease of dispersion indicates sperm accumulation in
the irradiated area (control, n = 5, RU1968F1, n = 6). Data shown are means ± SD.
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of many marine species, including the saprophytic fungus
Allomyces macrogynus, the tunicate Ciona intestinalis and
the seastar Asterias amurensis harbour CatSper genes (Cai
and Clapham, 2008; Cai et al., 2014). Sperm from these spe-
cies also undergo chemotaxis (Miller, 1975; Pommerville,
1978; Yoshida et al., 2002; Matsumoto et al., 2003).
RU1968F1 might reveal whether chemotaxis involves
CatSper. Third, the drug might help to define the diverse
functions of CatSper among mammalian sperm. For exam-
ple, mouse sperm undergo rotational motion that governs
rheotaxis in gradients of flow velocities (Miki and Clapham,
2013). By contrast, CatSper/ mouse sperm do not rotate
and fail to undergo rheotaxis, suggesting that Ca2+ influx
via CatSper channels is required. However, another study
describes rheotaxis as a passive process that does not require
Ca2+ influx (Zhang et al., 2016). CatSper recruit several pro-
teins into Ca2+-signalling domains that form a quadrilateral
arrangement along the flagellar membrane (Chung et al.,
2014; Chung et al., 2017). Targeted deletion of CatSper sub-
units disrupts these signalling domains (Chung et al., 2014,
Chung et al., 2017). Therefore, the motility defects of
CatSper/ mouse sperm might be caused by the lack of
Ca2+ influx via CatSper, by disruption of the supramolecular
flagellar ultrastructure, or by a combination of both. Fourth,
in human sperm, neither the role of oviductal CatSper li-
gands nor the role of CatSper during fertilization has been
fully established. This is due to the demanding challenge
to mimic the complex chemical, hydrodynamic and topo-
graphical environment of the oviduct in vitro (Xiao et al.,
2017). We envision the use of RU1968F1 as a tool to study
the role of CatSper and its ligands in human sperm, navi-
gating across artificial or explanted oviducts.
Finally, mutations in CATSPER genes (Avenarius et al.,
2009; Hildebrand et al., 2010) and the lack of functional
CatSper channels (Williams et al., 2015) are associated with
male infertility. In human sperm, at least in vitro,
RU1968F1 mimics the lack of CatSper channels, indicating
that inhibition of these channels in vivo might prevent fer-
tilization. Thus, RU1968F1 could serve as a lead structure
to develop new non-hormonal contraceptives. Drugs that
specifically target CatSper should exhibit no side effects,
because the expression of the channel is confined to
sperm.
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Figure S1 Relative stereochemistry at C18 and C20 in 3a.
Right panel: H-H COESY spectrum of 3a. C18-CH3 groups
were identified as singlets at δ = 0.73 ppm (blue, major iso-
mer) and δ = 0.80 ppm (red, minor isomer). CH3 groups at
C21 were identified as overlapping doublets (δ = 1.09 ppm
major isomer and δ = 1.10 ppmminor isomer), each of which
could be cross-referenced to a multiplet at δ> 2.5 ppm, which
consequently was assigned to the CH-group at C20. (Major
isomer, dashed blue lines, δ = 1.09 ppm→ δ = 2.64 ppm; mi-
nor isomer, dashed red lines, δ = 1.10 ppm → δ = 2.76 ppm).
Left panel: NOE experiments to assign relative stereochemis-
try between C18 and C20. Blue box: major isomer; irradiation
of the C18-CH3 singlet (δ = 0.73 ppm) results in a strong neg-
ative NOE resonance at δ = 2.64 ppm, indicating spatial prox-
imity of C18- and C20-protons. Cis configuration was
assigned for this isomer. Red box: minor isomer; irradiation
of the C18-CH3 singlet (δ = 0.80 ppm) results in no observ-
able NOE resonance at δ = 2.76 ppm, indicating no spatial
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proximity of C18- and C20-protons. Trans configuration was
assigned for this isomer.
Figure S2 Relative stereochemistry at C18 and C20 in 3b.
Right panel: H-H COESY spectrum of 3b. C18-CH3 groups
are easily identified as singlets at δ = 0.72 ppm (blue, major
isomer) and δ = 0.85 ppm (red, minor isomer). CH3 groups
at C21 are identified as doublets (δ = 1.16 ppm major isomer
and δ = 1.05 ppmminor isomer), each of which could be cross
referenced to a multiplet at δ > 2.5 ppm, which consequently
was assigned to the CH-group at C20. (Major isomer, dashed
blue lines, δ = 1.16 ppm → δ = 2.55 ppm; minor isomer,
dashed red lines, δ = 1.05 ppm → δ = 2.64 ppm). Left panel:
NOE experiments to assign relative stereochemistry between
C18 and C20. Blue box: major isomer; irradiation of the
C18-CH3 singlet (δ = 0.72 ppm) results in a strong negative
NOE resonance at δ = 2.55 ppm, indicating spatial proximity
of C18- and C20-protons. Cis configuration was assigned for
this isomer. Red box: minor isomer; irradiation of the C18-
CH3 singlet (δ = 0.85 ppm) results in no observable NOE res-
onance at δ = 2.64 ppm, indicating no spatial proximity of
C18- and C20-protons. Trans configuration was assigned for
this isomer.
Figure S3 The action of RU1968F1 itself in human sperm.
(A) RU1968F1-induced Ca2+ signals in human sperm. (B)
Dose–response relation of the RU1968F1-evoked signal am-
plitudes (n = 3). Error bars indicate SD. (C) RU1968F1-induced
Ca2+ signals in human sperm at 10 nM extracellular Ca2+. (D)
Changes in pHi evoked by RU1968F1 or NH4Cl in sperm
loaded with the pH indicator BCECF. The signals were re-
corded in the FluoStar. (E) Fraction of immotile sperm in the
absence (n = 9) and presence of the RU1968F1 (30 μM),
MDL12330A (100 μM), Mibefradil (60 μM), or NNC-55-0396
(30 μM) (n = 5). Error bars indicate SD. *P < 0.05 versus con-
trol. (F) Fraction of vital cells in the absence and presence of
the inhibitors (n = 5). Vitality was evaluated by the Eosin test,
performed according to theWHOmanual. Error bars indicate
SD. *P < 0.05 versus control (G) Fold increase in acrosome-
reacted sperm after treatment with RU1968F1 (30 μM),
Mibefradil (40 μM), or NNC-55-0396 (20 μM) (n = 10). Error
bars indicate SD. *P < 0.05 versus control.
Figure S4 RU1968F1 inhibits depolarization- and alkaline-
evoked Ca2+ signals in human sperm. (A) Ca2+ signals evoked
by mixing of sperm with pH 8.6-HTF and RU1968F1 in a
stopped-flow apparatus. The final pH after mixing was 8.1.
(B) Ca2+ signals evoked by mixing of sperm with K+-HTF
and RU1968F1 in a stopped-flow apparatus. The final K+
concentration after mixing was 51.25 mM.
Figure S5 RU1968F1 inhibits progesterone responses in
sperm bathed in NH4Cl. (A) Progesterone-induced Ca
2+ sig-
nals (500 nM) in human sperm bathed for 20 min in 30 mM
NH4Cl. (B) Dose–response relation of signals from (A). Mean
IC50: 3.1 ± 1.2 (n = 5).
Figure S6 Action of RU1968F2-F4 on their own and on
CatSper-mediated Ca2+ signals in human sperm populations.
(A) RU1968F2-inducedCa2+ signals in human sperm. (B) Proges-
terone (500 nM)-induced Ca2+ signals in human sperm in the
presence of RU1968F2; (C) Dose–response relation of the signal
amplitudes from (B) (IC50 = 1.6 μM). (D) RU1968F3-induced
Ca2+ signals in human sperm. (E) Progesterone-induced Ca2+
signals in the presence of RU1968F3. (F) Dose–response relation
of the signal amplitudes from (E) (IC50 = 2.7 μM). (G) RU1968F4-
induced Ca2+ signals in human sperm. (H) Progesterone-in-
duced Ca2+ signals in human sperm in the presence of
RU1968F4. (I) Dose–response relation of the signal amplitudes
from (H) (IC50 = 5.8 μM).
Figure S7 Action of RU1968F1 on Hv1 currents in human
sperm and ATP-evoked Ca2+ responses in mouse sperm. (A)
Voltage-gated proton currents recorded from a human sperm
cell before (blue) and after superfusion with RU1968F1 (red).
(B) Mean outward current before and after application of
RU1968F1 (n = 3). Arrow in panel (A) indicates the time point
at which outward currents were determined. Error bars indi-
cate SD. (C) ATP-evoked Ca2+ signals in CatSper1/ mouse
sperm in the absence and presence of RU1968F1. The Ca2+ re-
sponses were recorded in the FluoStar. ATP was injected at
t = 0 s.
Figure S8 RU1968F1 suppresses penetration of sperm into
viscous media. (A) Number of sperm at penetration distances
of 0–4 cm in a modified Kremer’s sperm-mucus penetration
test. Sperm were incubated in buffer (0) or RU1968F1
(n = 21). Error bars indicate SD. *P < 0.05 versus control (0,
without RU1968F1). #P < 0.05 versus progesterone without
RU1968F1 (B) Number of sperm after incubation in buffer
(0), progesterone, or progesterone plus RU1968F1 (n = 21). Er-
ror bars indicate SD. *P< 0.05 versus control, #P< 0.05 versus
progesterone without RU1968F1 (0, without progesterone).
(C) Number of sperm bathed in buffer (control) or progester-
one when the capillary included buffer (0) or RU1968F1
(n = 6). Error bars indicate SD. *P < 0.05 versus control (0,
without progesterone), #P < 0.05 versus progesterone with-
out RU1968F1 (0, without progesterone).
Figure S9 RU1968F1 inhibits CaV1.2 channels. Representa-
tive whole-cell current recorded from a HEK293T cell express-
ing human CaV1.2 + β2b + α2δ1 before (A) and after perfusion
of the cell with 50 μM RU1968F1 (B). (C) Plotting the mean
peak current versus voltage demonstrates the incomplete
block of CaV1.2 by RU1968F1 (n = 5). (D) Peak currents at
+20 mV recorded every 2 s while the cell was perfused with
external solution or solution containing 50 μM RU1968F1.
The reduction and recovery of the current during the wash-
in (red) and wash-out (blue) of RU1968F1, respectively, was
fitted with an exponential function. The time constants were
used to calculate an approximate affinity (kD) of 31 ± 9 μM
(n = 4).
Figure S10 RU1968F1 inhibits CaV3.2 channels. Representa-
tive whole-cell current recorded from a HEK293T cell express-
ing CaV3.2 before (A) and after perfusion of the cell with
RU1968F1 (B). (C) Plotting themean peak current versus volt-
age demonstrates the incomplete block of CaV3.2 by
RU1968F1 (n = 5). (D) Peak currents at +20mV recorded every
2 s while the cell was perfused with external solution or solu-
tion containing 50 μM RU1968F1. The reduction and recov-
ery of the current during the wash-in (red) and wash-out
(blue) of RU1968F1, respectively, was fitted with an exponen-
tial function. The time constants were used to calculate an ap-
proximate affinity (kD) of 16 ± 3 μM (n = 4).
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